Our World in Data

Anxiety treatment in the US has relied on tranquilizers, benzodiazepines, and antidepressants, with no new FDA-approved anxiety drugs since 2004

Anxiety affects a large share of people globally, and US FDA approvals show anxiety drug treatment shifting from 1950s tranquilizers to benzodiazepines and then antidepressants, with no new anxiety medications approved since 2004.

Resource use matters, but material footprints are a poor way to measure it

The material footprint metric, which aggregates resource use by weight, obscures critical environmental and socioeconomic issues. This matters because it misguides policy and public understanding of sustainability challenges.

Understanding the Mechanism of Antibiotics

This article explores the mechanisms by which antibiotics combat bacterial infections, detailing the various ways they target and disrupt bacterial cells, and the implications for human health.

Stay ahead with OwlBrief

A daily set of high-signal briefs — what happened, why it matters, what to watch next.

Newsletter

Get OwlBrief in your inbox

A fast, high-signal digest of the day’s most important events — plus the context that makes them make sense.

A handful of briefs — before your coffee gets cold.

No spam. Unsubscribe anytime. We don’t sell your email.